Neurodegeneration Prevented by Lentiviral Vector Delivery of GDNF in Primate Models of Parkinson's Disease
Top Cited Papers
- 27 October 2000
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 290 (5492) , 767-773
- https://doi.org/10.1126/science.290.5492.767
Abstract
Lentiviral delivery of glial cell line–derived neurotrophic factor (lenti-GDNF) was tested for its trophic effects upon degenerating nigrostriatal neurons in nonhuman primate models of Parkinson's disease (PD). We injected lenti-GDNF into the striatum and substantia nigra of nonlesioned aged rhesus monkeys or young adult rhesus monkeys treated 1 week prior with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Extensive GDNF expression with anterograde and retrograde transport was seen in all animals. In aged monkeys, lenti-GDNF augmented dopaminergic function. In MPTP-treated monkeys, lenti-GDNF reversed functional deficits and completely prevented nigrostriatal degeneration. Additionally, lenti-GDNF injections to intact rhesus monkeys revealed long-term gene expression (8 months). In MPTP-treated monkeys, lenti-GDNF treatment reversed motor deficits in a hand-reach task. These data indicate that GDNF delivery using a lentiviral vector system can prevent nigrostriatal degeneration and induce regeneration in primate models of PD and might be a viable therapeutic strategy for PD patients.Keywords
This publication has 25 references indexed in Scilit:
- Sequential Administration of GDNF into the Substantia Nigra and Striatum Promotes Dopamine Neuron Survival and Axonal Sprouting but Not Striatal Reinnervation or Functional Recovery in the Partial 6-OHDA Lesion ModelExperimental Neurology, 2000
- Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian ratGene Therapy, 1999
- Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defectJournal of Clinical Investigation, 1999
- Stable gene transfer to the nervous system using a non-primate lentiviral vectorGene Therapy, 1999
- Multiply attenuated lentiviral vector achieves efficient gene delivery in vivoNature Biotechnology, 1997
- Glial Cell Line-Derived Neurotrophic Factor: A Novel Therapeutic Approach to Treat Motor Dysfunction in Parkinson's DiseaseExperimental Neurology, 1997
- Dopaminergic Neurons Protected from Degeneration by GDNF Gene TherapyScience, 1997
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- Functional recovery in parkinsonian monkeys treated with GDNFNature, 1996
- Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. GeneralizationsJournal of Cerebral Blood Flow & Metabolism, 1985